首页> 外国专利> Corneal administration of iontophoresis crosslinking agents for the treatment of keratoconus and related ophthalmic compositions

Corneal administration of iontophoresis crosslinking agents for the treatment of keratoconus and related ophthalmic compositions

机译:离子电渗交联剂的角膜给药治疗圆锥角膜及相关眼科用组合物

摘要

An ophthalmic composition for use in the treatment of keratoconus by corneal iontophoresis characterized in that it comprises: A. crosslinking agents that allow the reinforcement of the structure of the cornea affected by keratoconus through interweaving and increase the links (crosslinking) between collagen fibers of the cornea and which have buffering properties and whose initial pH value is between 5 and 6, where the crosslinking agent is riboflavin, or a solution of riboflavin phosphate, or dehydrated sodium salt of riboflavin phosphate, or dehydrated sodium salt of riboflavin phosphate H2O, or dehydrated sodium salt of riboflavin phosphate 2H2O, and B. a buffer system in variable amounts such as to reach the pH value of the final solution of 5.5, and C substances that promote the passage of riboflavin or other photosensitizing and photopolymerizing substances through the corneal epithelium, allowing I tend to absorb by the corneal stroma itself, called bio-enhancers, and / or D. photosensitive and photopolymerizing substances that can be easily absorbed by the epithelium and that, like riboflavin, can also be activated by light to form a corneal crosslink , called photopotentiators.
机译:用于通过角膜离子电渗疗法治疗圆锥角膜的眼科用组合物,其特征在于,其包含:A.交联剂,其通过交织来增强受圆锥角膜影响的角膜的结构,并增加角膜的胶原纤维之间的连接(交联)。角膜,具有缓冲特性,其初始pH值在5至6之间,其中交联剂为核黄素,磷酸核黄素的溶液,磷酸核黄素的脱水钠盐或磷酸核黄素的脱水钠H2O或脱水磷酸核黄素2H2O的钠盐; B。可变数量的缓冲系统,以达到5.5最终溶液的pH值; C物质可促进核黄素或其他光敏和光聚合物质通过角膜上皮,使我倾向于被称为生物增强剂和/或D的角膜基质本身吸收。易于被上皮吸收的热敏感和光聚合物质,与核黄素一样,也可以被光激活以形成角膜交联,称为光增效剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号